Epi Vax Therapeutics, Inc. announced it raised $370,000 in an initial filing from an offering of $370,000
Epi Vax Therapeutics, Inc. announced it raised $370,000 in an initial filing from an offering of $370,000
02/22/21, 5:02 PM
Location
providenceMoney raised
$370,000
Industry
biotechnology
Round Type
seed
Company Info
Location
188 valley street
providence, rhode island, united states
Additional Info
EpiVax Therapeutics ('EVT'), an emerging biotechnology startup founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or prevent disease in the host.